July 17, 2023 /

Research Row Breakout Session: Impacting Downstream – PPMD 2023 Annual Conference

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Research Row: Impacting Downstream

  • Capricor Therapeutics (Cap-1002)
  • Edgewise Therapeutics (EDG-5506)
  • FibroGen (Pamrevlumab)
  • Antisense Therapeutics (ATL1102)
  • Cumberland Pharmaceuticals (Ifetroban)
2023 PPMD Annual Conference,
Conferences & Meetings

Join Our Mailing List